- Home
- IFN vs OPT Comparison
IFN vs OPT Comparison
Compare IFN & OPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IFN
- OPT
- Stock Information
- Founded
- IFN 1993
- OPT 1984
- Country
- IFN Singapore
- OPT Australia
- Employees
- IFN N/A
- OPT N/A
- Industry
- IFN Finance/Investors Services
- OPT Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- IFN Finance
- OPT Health Care
- Exchange
- IFN Nasdaq
- OPT Nasdaq
- Market Cap
- IFN 644.0M
- OPT 767.9M
- IPO Year
- IFN N/A
- OPT 2020
- Fundamental
- Price
- IFN $16.18
- OPT $3.34
- Analyst Decision
- IFN
- OPT Strong Buy
- Analyst Count
- IFN 0
- OPT 1
- Target Price
- IFN N/A
- OPT $12.00
- AVG Volume (30 Days)
- IFN 135.2K
- OPT 12.3K
- Earning Date
- IFN 01-01-0001
- OPT 08-30-2024
- Dividend Yield
- IFN 8.68%
- OPT N/A
- EPS Growth
- IFN N/A
- OPT N/A
- EPS
- IFN N/A
- OPT N/A
- Revenue
- IFN N/A
- OPT $261,859.00
- Revenue This Year
- IFN N/A
- OPT N/A
- Revenue Next Year
- IFN N/A
- OPT $46,864.64
- P/E Ratio
- IFN N/A
- OPT N/A
- Revenue Growth
- IFN N/A
- OPT N/A
- 52 Week Low
- IFN $14.40
- OPT $1.79
- 52 Week High
- IFN $21.25
- OPT $5.45
- Technical
- Relative Strength Index (RSI)
- IFN 26.45
- OPT 43.16
- Support Level
- IFN $17.22
- OPT $3.15
- Resistance Level
- IFN $17.28
- OPT $3.39
- Average True Range (ATR)
- IFN 0.26
- OPT 0.18
- MACD
- IFN -0.09
- OPT -0.00
- Stochastic Oscillator
- IFN 10.13
- OPT 27.49
About IFN India Fund Inc. (The)
India Fund Inc is an asset management company. The fund's investment objective is long-term capital appreciation, which it seeks to achieve by investing primarily in the equity securities of Indian companies. The company's portfolio is non-diversified closed-end management investment company across various sectors such as financials, consumer staples, information technology, materials, healthcare, consumer discretionary, industrials, telecommunication services, utilities and others. Geographically, all the business activity functions through the market of United States.
About OPT Opthea Limited
Opthea Ltd operates in one industry being the medical technology and healthcare. It is focused on developing biological therapeutics for eye diseases. The company is developing a novel biologic therapy, OPT-302, for the treatment of eye diseases. Its products are based on the intellectual property portfolio covering Vascular Endothelial Growth Factors C and D and R3 targets. Opthea's development activities are based on an intellectual property portfolio covering key targets Vascular Endothelial Growth Factors VEGF-C, VEGF-D and VEGF Receptor-3 for the treatment of diseases associated with blood and lymphatic vessel growth, as well as vascular leakage. The company geographically operates Australia and United States.